Industry News
New Handheld Device Enhances Early Detection and Treatment of Amblyopia

Researchers at the University of Missouri–St. Louis (UMSL) have developed a groundbreaking handheld ...

read more
New Handheld Device Enhances Early Detection and Treatment of Amblyopia
June 17, 2025
Heidelberg Engineering Launches ZinserLab to Drive Innovation in Ophthalmic Imaging

Heidelberg Engineering has officially announced the launch of ZinserLab, an innovation hub dedicated...

read more
Heidelberg Engineering Launches ZinserLab to Drive Innovation in Ophthalmic Imaging
June 17, 2025
FDA Clears Ocugen to Launch Phase 2/3 Confirmatory Trial of OCU410ST for Stargardt Disease

Ocugen has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase 2...

read more
FDA Clears Ocugen to Launch Phase 2/3 Confirmatory Trial of OCU410ST for Stargardt Disease
June 17, 2025
EMA Identifies Rare Risk of Vision Loss with Semaglutide-Based Therapies

The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has conclud...

read more
EMA Identifies Rare Risk of Vision Loss with Semaglutide-Based Therapies
June 16, 2025
PolyActiva Secures AUD $40 Million in Series C Funding to Advance PA5108 and PREZIA Drug Delivery Platform

PolyActiva has raised AUD $40 million in a Series C financing round to further the clinical developm...

read more
PolyActiva Secures AUD $40 Million in Series C Funding to Advance PA5108 and PREZIA Drug Delivery Platform
June 16, 2025
Zeteo Biomedical Secures U.S. and EU Patents for Next-Generation Drug Delivery Technologies

Zeteo Biomedical has announced the issuance of two new patents—one in the United States and one in t...

read more
Zeteo Biomedical Secures U.S. and EU Patents for Next-Generation Drug Delivery Technologies
June 13, 2025
SpliceBio Raises $135 Million in Series B to Advance Gene Therapy for Stargardt Disease

SpliceBio has announced the successful closing of a $135 million Series B financing round to acceler...

read more
SpliceBio Raises $135 Million in Series B to Advance Gene Therapy for Stargardt Disease
June 13, 2025
University of Colorado Anschutz Medical Campus Receives $40M Gift for Eye Research

The Department of Ophthalmology at the University of Colorado Anschutz Medical Campus has received a...

read more
University of Colorado Anschutz Medical Campus Receives $40M Gift for Eye Research
June 12, 2025
Qlaris Bio Advances Development of Fixed-Dose Combination Therapy for Glaucoma

Qlaris Bio has announced the development of a novel, preservative-free fixed-dose combination therap...

read more
Qlaris Bio Advances Development of Fixed-Dose Combination Therapy for Glaucoma
June 12, 2025
GenEditBio Doses First Patient in Investigator-Initiated Trial of GEB-101 for TGFBI Corneal Dystrophy

GenEditBio Limited has announced the successful dosing of the first patient in an investigator-initi...

read more
GenEditBio Doses First Patient in Investigator-Initiated Trial of GEB-101 for TGFBI Corneal Dystrophy
June 11, 2025
More